Fortress Biotech (FBIO) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
Powered by 
Analysis
Fortress Biotech (FBIO) Net Income towards Common Stockholders (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -268.65% |
| Sep 30, 2025 | -72.48% |
| Jun 30, 2025 | 205.03% |
| Mar 31, 2025 | -31.73% |
| Dec 31, 2024 | 35.82% |
| Sep 30, 2024 | -12.75% |
| Jun 30, 2024 | 25.31% |
| Mar 31, 2024 | -58.23% |
| Dec 31, 2023 | -60.03% |
| Sep 30, 2023 | 73.80% |
| Jun 30, 2023 | -14.32% |
| Mar 31, 2023 | 18.55% |
| Dec 31, 2022 | -17.90% |
| Sep 30, 2022 | -4.94% |
| Jun 30, 2022 | 52.78% |
| Mar 31, 2022 | 27.53% |
| Dec 31, 2021 | -25.88% |
| Sep 30, 2021 | -19.27% |
| Jun 30, 2021 | -42.19% |
| Mar 31, 2021 | -22.07% |